Translatoric biomedical research
The R&D division of the Department of Medical and Pharmaceutical Biotechnology is internationally recognised as an academic innovative centre in translatoric biomedical research. Based on sophisticated and unique cell-based technologies, our R&D activities focus on the rapid identification of clinically effective remedies for the prevention and treatment of human diseases such as cancer and inflammatory disorders or for the promotion of tissue regeneration and wound healing.
To achieve these goals, we have established multiple (inter)national collaborative ventures with the pharmaceutical industry, with small- and medium-sized biotech companies, and with clinical centres and universities.
Working in close collaboration with our industrial partners, we plan to commercially exploit the novel technologies through patenting and licensing.
The infrastructure established by the IMC University of Applied Sciences Krems and by the biomedical research projects with a total volume of 3.6 mill. euros is instrumental in ensuring high-quality training and in preparing the next generation of young scientists for careers in industry or the academic world.
The established research and educational programs represent a major incentive for biotech and start-up companies to settle in the Krems research area.